Evidence map›Paper›PMID 30116316›Full record

ArticleExperimental and therapeutic medicine2018

MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis.

Xintao Tian, Chunpeng Yu, Lei Shi, Dan Li, Xiaoxue Chen, Di Xia, Jingwei Zhou, Wanqun Xu, Chengtai Ma, Lihua Gu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xintao TianDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Chunpeng YuDepartment of Intervention, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Lei ShiDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Dan LiDepartment of Cardiovascular Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Xiaoxue ChenDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Di XiaDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Jingwei ZhouDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Wanqun XuDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Chengtai MaDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Lihua GuDepartment of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Yi AnDepartment of Cardiovascular Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigated the expression of microRNA (miRNA or miR)-199a-5p in the peripheral blood of patients with primary hypertension, and examined its mechanism of action in vascular endothelial cell injury induced by hypertension. A total of 57 patients with primary hypertension, who were treated at the Affiliated Hospital of Qingdao University (Qingdao, China) between December 2014 and November 2015 were included in the present study. Peripheral blood was collected from all patients. The expression of miR-199a-5p was measured using reverse-transcription quantitative polymerase chain reaction analysis. Human umbilical vein endothelial cells (HUVECs) were divided into negative control, miR-199a-5p mimics and rescue (co-transfected with miR-199a-5p mimics and inhibitor) groups. After transfection, the proliferation and apoptosis of HUVECs were evaluated by a Cell Counting Kit-8 assay, a bromodeoxyuridine incorporation assay and flow cytometry. Western blot analysis was used to determine the expression of proteins involved in autophagy-associated and adenosine monophosphate kinase (AMPK)/unc-51 like autophagy activating kinase 1 (ULK1) signaling pathways. Laser scanning confocal microscopy and electron microscopy were used to observe the autophagy of HUVECs. The expression of miR-199a-5p was elevated in peripheral blood of patients with hypertension, and was correlated with the progression of hypertension. Overexpression of miR-199a-5p inhibited the proliferation and promoted the apoptosis of HUVECs. Upon expression of miR-199a-5p, the transition between microtubule-associated proteins 1A/1B light chain 3B (LC3B)I and LC3BII proteins was inhibited, the expression of p62 protein was upregulated. In addition, miR-199a-5p decreased the numbers of autophagosomes and autolysosomes in HUVECs. The present study demonstrated that expression of miR-199a-5p is positively correlated with the severity of hypertension. Expression of miR-199a-5p aggravated vascular endothelial injury by inhibiting autophagy and promoting the apoptosis of HUVECs via downregulation of the AMPK/ULK1 signaling pathway.

Indexed as

apoptosisautophagymicroRNA-199a-5pprimary hypertensionvascular endothelial cell injury

Identifiers

PMID30116316
PMCPMC6090226
OpenAlexW2807636854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.